Figure 1From: pERK1/2 silencing sensitizes pancreatic cancer BXPC-3 cell to gemcitabine-induced apoptosis via regulating Bax and Bcl-2 expression Effects of gemcitabine on ERK signaling pathways in BXPC-3. Anti-ERK and anti-pERK1/2 monoclonal antibodies were used to perform in Western blotting. Cells were exposed to 25 uM gemcitabine for 0–72 h. The levels of ERK1/2 and pERK1/2 were measured by densitometry of autoradiographs.Back to article page